Cellectis
CLLS
57 hedge funds and large institutions have $213M invested in Cellectis in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.
320% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
62% more call options, than puts
Call options by funds: $3.27M | Put options by funds: $2.02M
36% more funds holding
Funds holding: 42 → 57 (+15)
28% more capital invested
Capital invested by funds: $167M → $213M (+$46M)
4.05% more ownership
Funds ownership: 16.58% → 20.63% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$9.53M |
| 2 |
Morgan Stanley
New York
|
+$8.79M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.62M |
| 4 |
BlackRock
New York
|
+$4.13M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$4.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$11M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.88M |
| 3 |
Lazard Asset Management
New York
|
-$1.72M |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$569K |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
-$501K |
CLLS Hedge Fund Activity: Q4 2017 in Review
57 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2017, worth a combined $213M — up 28% from $167M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CLLS positions and 5 closed out — a net gain of 16 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $9.53M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $11M sold.
- 57 institutional investors held Cellectis (CLLS) as of Q4 2017, up from 42 in Q3 2017.
- Funds reported $213M of Cellectis stock for Q4 2017, up 28% quarter-over-quarter.
- 21 funds opened new Cellectis positions in Q4 2017 and 5 closed out, a net change of +16 holders.
- The largest Cellectis buyer in Q4 2017 was Perceptive Advisors, an estimated $9.53M added.
- The largest Cellectis seller in Q4 2017 was Farallon Capital Management, an estimated $11M sold.
Based on aggregated 13F filings for Q4 2017.